Evidence map›Paper›PMID 36292015›Full record

ReviewDiagnostics (Basel, Switzerland)2022

Single CT Appointment for Double Lung and Colorectal Cancer Screening: Is the Time Ripe?

Mario Mascalchi, Giulia Picozzi, Donella Puliti, Giuseppe Gorini, Paola Mantellini, Lapo Sali

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mario MascalchiDepartment of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, 50100 Florence, Italy.ORCID 0000-0002-5537-2982
Giulia PicozziDivision of Epidemiology and Clinical Governance, Institute for Study, Prevention and Network in Oncology (ISPRO), 50139 Florence, Italy.ORCID 0000-0003-2363-3807
Donella PulitiDivision of Epidemiology and Clinical Governance, Institute for Study, Prevention and Network in Oncology (ISPRO), 50139 Florence, Italy.
Giuseppe GoriniDivision of Epidemiology and Clinical Governance, Institute for Study, Prevention and Network in Oncology (ISPRO), 50139 Florence, Italy.ORCID 0000-0002-1413-5948
Paola MantelliniDivision of Screening, Institute for Study, Prevention and Network in Oncology (ISPRO), 50139 Florence, Italy.
Lapo SaliDepartment of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, 50100 Florence, Italy.ORCID 0000-0002-3366-1660
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Annual screening of lung cancer (LC) with chest low-dose computed tomography (CT) and screening of colorectal cancer (CRC) with CT colonography every 5 years are recommended by the United States Prevention Service Task Force. We review epidemiological and pathological data on LC and CRC, and the features of screening chest low-dose CT and CT colonography comprising execution, reading, radiation exposure and harm, and the cost effectiveness of the two CT screening interventions. The possibility of combining chest low-dose CT and CT colonography examinations for double LC and CRC screening in a single CT appointment is then addressed. We demonstrate how this approach appears feasible and is already reasonable as an opportunistic screening intervention in 50-75-year-old subjects with smoking history and average CRC risk. In addition to the crucial role Computer Assisted Diagnosis systems play in decreasing the test reading times and the need to educate radiologists in screening chest LDCT and CT colonography, in view of a single CT appointment for double screening, the following uncertainties need to be solved: (1) the schedule of the screening CT; (2) the effectiveness of iterative reconstruction and deep learning algorithms affording an ultra-low-dose CT acquisition technique and (3) management of incidental findings. Resolving these issues will imply new cost-effectiveness analyses for LC screening with chest low dose CT and for CRC screening with CT colonography and, especially, for the double LC and CRC screening with a single-appointment CT.

Indexed as

chest CTcolorectal cancercomputed tomographyCT colonographylung cancerscreening

Identifiers

PMID36292015
PMCPMC9601268
OpenAlexW4297347763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.